Recovery & Repair
KPV
The C-terminal tripeptide of alpha-MSH, studied for inflammatory modulation without the pigmentary effects of the parent hormone.
- Physician reviewed
- 503A pharmacy compounded
- Patient-specific prescription
Formats & pricing
- 10mg vial — reconstituted injectable$232
- Oral capsule — compounded$248
Pricing reflects the compounded preparation and physician review. Final therapy and dosing are determined only after your intake is reviewed.
Overview
What is KPV?
KPV is a three-amino-acid fragment (lysine-proline-valine) of alpha-melanocyte-stimulating hormone. Research interest centers on its inflammatory signaling activity, particularly in gastrointestinal and dermatologic contexts.
Mechanism
How it works
Preclinical work suggests KPV may act intracellularly on inflammatory transcription pathways in epithelial and immune cells, which is why it is often discussed for mucosal tissue rather than systemic immunosuppression.
Wellness support
Potential wellness support areas
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
- Explored within gut-focused wellness protocols
- Discussed for inflammatory skin concerns
- Potential support for immune balance
- Frequently paired with BPC-157 for gut protocols
Administration
Format & dosing
Prescribed as a daily subcutaneous injection, or as an oral capsule when a gut-local effect is the goal. Your physician chooses the route.
Labs & monitoring
Labs, testing & monitoring
Your physician determines the final testing requirements for KPV after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status
Provider Determines Testing
Commonly reviewed at baseline
- CBC
- Comprehensive metabolic panel (CMP)
- hs-CRP
Follow-up & monitoring
Symptom-led follow-up. Inflammatory markers may be repeated if they were abnormal before starting.
Who may not be a candidate
- Pregnancy or nursing
- Active malignancy without oncology clearance
- Known hypersensitivity to the preparation
Medication interactions
Your physician reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Safety
Safety & considerations
Compounded medication, not FDA-approved. Review autoimmune conditions and immunosuppressive medications with your physician before starting.
Regulatory status: Compounded. Evidence level: Preclinical. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed physician after review of your history.
Related therapies
Recovery & Repair
BPC-157
Connective tissue repair, joint mobility, and gut healing support.
Provider Determines Testing
Recovery & Repair
TB-500
Systemic tissue repair, flexibility, and injury recovery support.
Provider Determines Testing
Recovery & Repair
BPC-157 / TB-500
Dual-action recovery stack for tissue repair and systemic healing.
Provider Determines Testing
Physician reviewed
Every protocol is approved by a licensed physician.
503A compounded
Prepared by licensed US compounding pharmacies.
Patient-specific Rx
Prescriptions are issued in your name only.
No membership
No concierge fee and no subscription to browse or begin.